Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to -$231.0 million.

  • Select Medical Holdings' Cash from Investing Activities rose 2768.28% to -$32.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$201.9 million, marking a year-over-year increase of 585.9%. This contributed to the annual value of -$231.0 million for FY2024, which is 1395.5% up from last year.
  • Latest data reveals that Select Medical Holdings reported Cash from Investing Activities of -$231.0 million as of FY2024, which was up 1395.5% from -$268.5 million recorded in FY2023.
  • Over the past 5 years, Select Medical Holdings' Cash from Investing Activities peaked at -$115.4 million during FY2020, and registered a low of -$268.5 million during FY2023.
  • For the 5-year period, Select Medical Holdings' Cash from Investing Activities averaged around -$219.6 million, with its median value being -$231.0 million (2024).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first surged by 6357.99% in 2020, then plummeted by 12244.24% in 2021.
  • Annual analysis of 5 years shows Select Medical Holdings' Cash from Investing Activities stood at -$115.4 million in 2020, then crashed by 122.44% to -$256.6 million in 2021, then rose by 11.79% to -$226.3 million in 2022, then decreased by 18.62% to -$268.5 million in 2023, then grew by 13.96% to -$231.0 million in 2024.
  • Its Cash from Investing Activities was -$231.0 million in FY2024, compared to -$268.5 million in FY2023 and -$226.3 million in FY2022.